Email Us
Contact Us
Google-play Apple Rss Facebook-f X-twitter Instagram Youtube Pinterest Behance
The Law Offices of Frank R. Cruz
NOTICIAS

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against WM Technology, Inc. (MAPS)

The Law Offices of Frank R. Cruz reminds investors of the December 16, 2024, deadline to file a lead plaintiff motion in the class action lawsuit against WM Technology, Inc. (NASDAQ: MAPS). The lawsuit alleges that the company made negligent misrepresentations about a key metric, Monthly Active Users (MAUs), and failed to maintain adequate internal controls. Disclosures about manipulated MAUs and SEC charges led to significant stock price declines, injuring investors. Shareholders who acquired WM Technology securities between May 25, 2021, and September 24, 2024, may participate in the lawsuit.

Read More
Bronstein, Gewirtz & Grossman LLC
NOTICIAS

MQ INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marqeta, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Marqeta, Inc. (NASDAQ: MQ) for alleged securities law violations. The case targets individuals and entities who purchased Marqeta securities between August 7, 2024, and November 4, 2024. The lawsuit claims Marqeta misrepresented regulatory challenges, issued misleading guidance, and caused investors to suffer losses when the truth emerged. Affected investors can join the case or seek lead plaintiff status by February 7, 2025. Legal representation is on a contingency fee basis.

Read More
Celltrion
NOTICIAS

Celltrion receives positive CHMP recommendation for approval of three biosimilars in the European Union

Celltrion announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for three biosimilars: Eydenzelt (aflibercept), Stoboclo (denosumab), and Avtozma (tocilizumab). These biosimilars are set to address conditions in ophthalmology, bone diseases, and immunology. Clinical trials demonstrated therapeutic equivalence, safety, and efficacy comparable to their reference products, such as Eylea®, Prolia®, and RoActemra®. This milestone strengthens Celltrion’s leadership in the European biosimilar market, offering innovative and affordable treatments. The final approval now awaits the European Commission’s decision.

Read More
Kahn Swick & Foti
NOTICIAS

CASSAVA SCIENCES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. – SAVA

Kahn Swick & Foti, LLC (“KSF”) reminds investors of the February 10, 2025, deadline to file as lead plaintiffs in the class action lawsuit against Cassava Sciences, Inc. (NasdaqCM: SAVA). The lawsuit alleges that Cassava failed to disclose material information during the Class Period (February 7, 2024–November 24, 2024). On November 25, 2024, the company reported that its drug simufilam failed to meet key endpoints in a Phase 3 trial, causing an 83% stock price drop from $26.48 to $4.30 per share.

Read More

SALES

miguel borges

miguel@dprimeramano.org

5385 Franklin Blvd g, Sacramento, CA 95820, United States

Play Store
Apple Store
Behance Rss Facebook Instagram Pinterest Twitter Youtube

Suscribirse al boletín informativo

Email Subscription Form

Copyright © Todas las marcas son propiedad de la respectiva empresa o de BORGES MEDIA INC. Queda prohibida la reproducción total o parcial de cualquiera de los contenidos que aquí aparecen, así como su traducción a cualquier idioma sin autorización escrita de su propietario, la mejor revista de Sacramento. Consulte nuestra  Política de Privacidad.

Top Categories

(14) VIAJES

(10) SALUD

(14) REVISTA

(6) POLÍTICA

Popular News

67th Annual Grammy Awards

67th Annual Grammy Awards: Honoring

Zepp Health Corporation

Zepp Health to Showcase Groundbreaking

Spanish Magazine in Sacramento

Saborea Sacramento: Una aventura culinaria

Menu